Epigenomics AG (XETRA:ECX)

European company
add to virtual portfolio
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - ECX

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - ECX

  • Market Cap€37.230m
  • SymbolXETRA:ECX
  • IndustryHealthcare
  • SectorDiagnostics & Research
  • Currency
  • ISINDE000A11QW50

Company Profile

Epigenomics AG is a molecular diagnostics company, focuses on developing and commercializing in vitro diagnostic liquid biopsy tests for the screening, early detection, and diagnosis of cancer. The company develops and markets procedures and devices for the production in quantity of particular epigenetic parameters such as DNA methylation patterns as well as the information technology bases necessary for their procurement and evaluation. It is engaged in the development of novel molecular diagnostic products for cancer. The company products include Epi proColon, Epi BiSKit, HCCBloodTest, and Epi proLung. The company operates in Europe, North America, Asia, and the Rest of the world.Epigenomics AG is a molecular diagnostics company. The company is engaged in developing and commercializing the proprietary products in vitro diagnostic test for screening, early detection and diagnosis of cancer.

Latest ECX news

Currently there for this company. Visit our news hub for other news .